본문 바로가기
KERD
논문KCI 등재

전략적 협력 네트워크가 기업의 성과에 미치는 영향에 관한 연구 : 글로벌 바이오제약기업을 중심으로

Empirical Study on the Effect of the network position and diversification of strategic alliance on firm performance in biopharmaceutical industry

이상훈
산업개발연구소 (kyungsung university)|2019.06|산업혁신연구 (Journal of Industrial Innovation)|제35권 제2호|pp. 1-31|DOI 10.22793/indinn.2019.35.2.001

0

조회

0

다운로드

7

인용

0

참고문헌

키워드

Firm performance기업성과전략적 제휴panel regression바이오제약산업biopharmaceutical industrynetwork position네트워크포지션네트워크다각화Strategic alliance networkNetwork diversification

초록

본 연구는 바이오제약기업의 전략적 제휴 네트워크가 기업 성과에 미치는 영향에 대해서 파악하기 위해서 1984년부터 2010년동안 543개의 글로벌 바이오제약기업을 대상으로 패널회귀분석을 실시하였다. 그 결과, 첫째, 기업의 전략적 제트워크 포지션과 기업 성과의 관계의 경우, 전략적 제휴 네트워크의 중심에 위치해 있는 기업은 혁신 성과에 긍정적인 영향을 미치는 것으로 파악되었지만, 재무성과와는 직접적인 관계가 존재하지 않는 것으로 나타났다. 또한 매개 중심성과 기업성과와의 유의한 관계가 나타나지 않은 것으로 파악되었다. 둘째, 전략적 제휴 네트워크의 다각화 정도는 혁신성과에는 통계적으로 유의미하게 나타나 긍정적인 영향을 미치는 것으로 나타났다. 하지만 전략적 제휴 네트워크의 다각화 정도는 재무 성과와는 관계가 없는 것으로 파악되었다. 즉, 바이오제약기업의 전략적 제휴의 목적은 직접적인 성과를 위한 협력보다는 보다 새로운 기술 및 신약 물질의 발견을 통한 혁신을 위한 수단으로 작용하는 것으로 파악되었다. 그래서 특히 산업 내 다각화 정도와 혁신성과와의 관계 역시 유의한 것으로 나타났다. 마지막으로 바이오제약기업의 산업간 다각화정도는 재무성과와 높은 관계를 맺고 있는 것으로 파악되었는데 기업은 재무성과를 개선시키기 위한 방안으로 산업간 전략적 제휴 네트워크의 다각화 실행하고 결과적으로 이를 통해 기업의 다각화 및 수익개선을 꾀하는 결과가 통계적으로도 유의한 결과값을 보인 것으로 보인다. 본 연구는 기업들이 전략적 제휴를 통해 얻는 외부 원천들과 기업들의 성과를 파악함으로써, 생명공학과 제약산업의 육성을 위한 정책적 시사점을 제공할 수 있을 것으로 기대된다.

Abstract

In this study, we focus on identifying the effect of network position and diversification of strategic alliance on firm performance in biopharmaceutical industry. first, as a result of examining the relationship between network position of strategic alliance and firm performance, we find that firms located at the center in strategic alliance network positively impact innovation performance, but there is no direct relationship with financial performance. In addition, there is no significant relationship between mediation location in strategic alliance network and corporation performance. Second, the degree of diversification in strategic alliance network has a statistically significant positive effect on innovation performance. However, the degree of diversification is not related to financial performance. It means that the purpose of the strategic alliance of biopharmaceutical firms is to discover and gain new technologies or drug substance for their product innovation rather than for their financial improvement. Therefore, the relationship between intra-diversification and innovation performance is also significantly related. Finally, we find the degree of inter-diversification has high relationship with financial performance. It means that irms have inter-diverse relationship of strategic alliance with other firms to improve their financial performance and profit. this results are expected to provides useful information to identify the determinants relevant to their performance when they decide alliance strategy of diversification in alliance network.

참고문헌 (63)

  1. 김민철, "해외 기업 및 R&D센터의 유치 대상 선정에 관한 사례 연구 −J지역 내 바이오산업을 위한−", 산업혁신연구, 24(2), pp.169~187 (2008), 산업개발연구소[DOI]
  2. 안건호, "우리나라 중소기업의 혁신역량과 성과", 산업혁신연구, 33(1), pp.153~176 (2017), 산업개발연구소[DOI]
  3. 장완진, "개방형 혁신 전략에서 개방성(openness)과 전유 전략의 관계에 대한 연구: 국내 중소 제조업을 중심으로", 산업혁신연구, 34(4), pp.21~46 (2018), 산업개발연구소[DOI]
  4. Arora, A., "The Nature and the Extent of the Market for Technology in Biopharmaceuticals", International Conference on Technology Policy and Innovation: Economic and Historical Perspectives (2000)
  5. Barkema, H. G., "Working abroad, working with others: How firms learn to operate international joint ventures", Academy of Management Journal, 40(2), pp.426~442 (1997)
  6. Barley, S. R., "Networks and Organizations:Structure, Form, and Action", pp.311~347 (1992), Harvard Business School Press
  7. Barney, J., "Firm resources and sustained competitive advantage", Journal of Management, 17, pp.199~120 (1991)
  8. Burgers, W. P., "A theory of global strategic alliances: The case of the global auto industry", Strategic Management Journal, 14(6), pp.419~432 (1993)
  9. Burt R. S., "Structural holes: The social structure of competition" (1992), Harvard University Press
  10. Caner, T., "When a firm’s centrality in R&D alliance network is (not) the answer for invention: The interaction of centrality, inward and outward knowledge transfer", Journal of Engineering and Technology Management, 33, pp.193~209 (2014)
  11. Coleman, J. S., "Foundations of Social Theory" (1990), The Belknap Press of Harvard University Press
  12. Conner. K., "A resource-based theory of the firm: Knowledge versus opportunism", Organization Science, 7(477), pp.477~501 (1996)
  13. Danzon, P., "Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances", Journal of Health Economics, 24, pp.317~339 (2005)
  14. Dosi, G., "The Nature and Dynamics of Organizational Capabilities" (2000), Oxford University Press
  15. Dougherty, D., "Sustained product innovation in large, mature organizations: Overcoming innovation-to-organization problems", Academy of Management Journal, 39, pp.1120~1153 (1996)
  16. Dubofsky, P., "Diversification and measures of performance:additional empirical evidence", Academy of Management Journal, 30, pp.597~608 (1987)
  17. Dundas, K., "Implementing the unrelated product strategy", Strategic Management Journal, 3, pp.287~301 (1982)
  18. Dussauge, P., "Learning from competing partners:outcomes and durations of scale and link alliances in Europe, north America and Asia", Strategic Management Journal, 21, pp.99~126 (2000)
  19. Farjoun, M., "The independent and joint effect of the skill and physical bases of relatedness in diversification", Strategic Management Journal, 19, pp.611~630 (1998)
  20. Freeman, L., "A set of measures of centrality based on betweenness", Sciometry, 40(1), pp.35~41 (1977)
  21. Freeman, L., "Centrality in social networks conceptual clarification", Social Networks, 1, pp.215~239 (1978)
  22. Galbraith, J. R., "Organizational design" (1977), Addison-Wesley
  23. Garcia-vega, M., "Does technological diversification promote innovation?: An empirical analysis for European firms", Research Policy, 35, pp.230~246 (2006)
  24. Gay, B., "Innovation and network structural dynamics: Study of the alliance network of a major sector of the biotechnology industry", Research Policy, 34(10), pp.1457~1475 (2005)
  25. Geringer, J., "Diversification strategy and internationalization: Implications for MNE performance", Strategic Management Journal, 10, pp.109~119 (1989)
  26. Gimeno, J., "Multimarket contact, economies of scope, and firm performance", Academy of Management Journal, 42, pp.239~259 (1999)
  27. Gould, R., "Structures of median: A formal approach to brokerage in transaction networks", Sociological Methodology, 19, pp.89~126 (1989)
  28. Granovetter, M., "The strength of weak ties", American Journal of Sociology, 78, pp.1360~1380 (1973)
  29. Gresov, C., "The context of interunit influence attempts", Administrative Science Quarterly, 38, pp.252~276 (1993)
  30. Guan, J., "The impact of university-industry collaboration networks on innovation in nanobiopharmaceuticals", Technological Forecasting and Social Change, 80(7), pp.1271~1286 (2013)
  31. Hagedoorm, J., "Inter-firm R&D partnerships: an overview of major trends and patterns since 1960", Research Policy, 31, pp.477~492 (2002)
  32. Hill, T., "Artificial neural network models for forecasting and decision making", International Journal of Forecasting, 10, pp.5~15 (1994)
  33. Ibarra, H, "Network, centrality, power, and innovation involvement: Determinants of technical and administrative roles", Academy of Management Journal, 36, pp.471~501 (1993)
  34. Jacob, J., "Alliance network configurations and the co-evolution of firms' technology profiles: An analysis of the biopharmaceutical industry", Technology Forecasting & Social Change, 120, pp.90~102 (2017)
  35. Koka, B. R., "Strategic alliances as social capital: A multidimensional view", Strategic Management Journal, 23, pp.795~816 (2002)
  36. Lerner, J., "Do equity financing cycles matter? evidence from biotechnology alliances", Journal of Financial Economics, 67(3), pp.411~446 (2003)
  37. Li, S., "The effect of within-industry diversification on firm performance: synergy creation, multi-market contact and market structuration", Strategic Management Journal, 25, pp.1131~1153 (2004)
  38. Lauman, E., "Networks of collective action" (1976), Academic
  39. Mani, S., "Product alliances, alliance networks, and shareholder value: Evidence from the biopharmaceutical industry", International Journal of Research in Marketing, 32, pp.9~22 (2015)
  40. Markides. C., "Related diversification, core competences, and corporate performance", Strategic Management Journal, 15, pp.149~167 (1994)
  41. Markides C., "Corporate diversification and organizational structure: A resource-based view", Academy of Management Journal, 39, pp.340~367 (1996)
  42. Mazzola, E., "Network Positions and the Probability of Being Acquired: An Empirical Analysis in the Biopharmaceutical Industry", British Academy of Management, 27, pp.516~533 (2016)
  43. Mazzola, E., "Network embeddedness and new product development in the biopharmaceutical industry: The moderating role of open innovation flow", International Journal of Production Economics, 160, pp.106~119 (2015)
  44. Nicholson, S., "Biotech-pharmaceutical alliances as a signal of asset and firm quality", Journal of Business, 78(4), pp.1433~1464 (2003)
  45. Nohria, N., "Global strategic linkages and industry structure", Strategic Management Journal, 12, pp.105~124 (1991)
  46. Penrose, E. T., "The Theory of the Growth of the Firm" (1959), Oxford UniversityPress
  47. R&D performance, collaborative arrangements, and the market-for-know-how: a test of the ‘lemons’ hypothesis in biotechnology, "Pisano GP.", Harvard Business School, 97~105 (1997)
  48. Powell, W. W., "Inter-organizational collaboration in the biotechnology industry", Journal of Institutional and Theoretical Economics, 120(1), pp.197~215 (1996)
  49. Roijakkers, N., "Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks", Research Policy, 35, pp.431~446 (2006)
  50. Rosenkopf L., "Investigating the Microstructure of Network Evolution:Alliance Formation in the Mobile Communications Industry", Organization Science, 19(5), pp.669~806 (2008)
  51. Schilling, M., "Disentangling the theories of firm boundaries: A path model and empirical test", Organization Science, 13, pp.387~401 (2002)
  52. Schilling, M., "Interfirm collaboration networks: The impact of large-scale network structure on firm innovation", Management Science, 53(7), pp.1113~11267 (2007)
  53. Shan, W., "Inter-firm cooperation and starup innovation in the biotechnology industry", Strategic Management Journal, 15(5), pp.387~394 (1994)
  54. Stern, I., "Within-business diversification in technology-intensive industries", Strategic Management Journal, 25, pp.487~505 (2004)
  55. Stuart, T., "Vertical alliance networks: The case of university-biotechnology-pharmaceutical alliance chains", Research Policy, 36, pp.477~498 (2007)
  56. Teece, D. J., "Profiting from technological innovation-implications for integration, collaboration, licensing and public policy", Research Policy, 15(6), pp.285~305 (1986)
  57. Teece, D., "Capturing value from knowledge assets: The new economy, markets for know-how, and intangible assets", California Management Review, 40, pp.55~79 (1998)
  58. Tsai, W, "Knowledge transfer in intraorganizational networks: Effects of network position and absorptive capacity on business unit innovation and performance", Academy of Management Journal, 44(5), pp.996~1004 (2001)
  59. Tsai, W., "Social Capital and Value Creation: The Role of Intrafirm Networks", Academy of Management Journalm, 41(4), pp.464~476 (1998)
  60. Van de Ven, A, "Central problems in the management of innovation", Management Science, 32, pp.590~607 (1986)
  61. Walker, G., "Social capital, structural holes and the formation of an industry network", Organization Science, 8, pp.109~125 (1997)
  62. Wasserman, S., "Social network analysis: Methods and applications" (1994), Cam-bridge University Press
  63. Watanabe, C., "Technological diversification and firm's techno-economic structure: An assessment of Canon's sustainable growth trajectory", Technological Forecasting and Social Change, 72(1), pp.11~27 (2005)

관련 논문AI추천

외부 네트워크와 기업성과 : 미국 바이오산업을 중심으로김진웅, 노영진, 이상규기술경영경제학회 · 기술혁신연구2010 · 제18권 제1호전략적 제휴 포트폴리오 다양성이 제휴강도와 성과 간의 관계에 미치는 영향한상연한국혁신학회 · 한국혁신학회지2021 · 제16권 제1호기업의 제휴 집약도와 지식기반이 혁신성과에 미치는 영향: 지식기반 폭과 깊이의 조절효과를 중심으로강기현, 강진아, 최승철한국전략경영학회 · 전략경영연구2015 · 제18권 제1호양손잡이 제휴(Ambidextrous Alliance)가 기업 성과에 미치는 영향곽주영, 정도범기술경영경제학회 · 기술혁신연구2012 · 제20권 제1호국내 첨단산업의 네트워크 구조변화와 네트워크특성이 기업의 혁신성과에 미치는 영향박병진, 이종찬한국전략경영학회 · 전략경영연구2016 · 제19권 제2호탐색적/활용적 제휴와 인수의 상호작용: 신제품 출시에 미치는 영향송상영, 오유진, 이종국한국상품학회 · 상품학연구2014 · 제32권 제6호

이 간행물의 다른 논문 (7건)

Ownership and Firm Performance : Evidences from Privatization IPOs around the World최승두pp. 33-59자영업 혼잡률 개념을 이용한 한국 서비스 자영업 분석서환주, 스티븐에스.밤멜pp. 61-89아웃소싱이 기업 경영성과에 미치는 영향 : 생산성과 수익성을 중심으로김종호, 남종석pp. 91-114Empirical Analysis on Inventory Turnover in South Korea곽진경pp. 115-129공급자의 혁신성과 국제 산업재 구매결정의 관계: IPA 기법을 적용하여황두희, 조은호, 정선양pp. 131-158
원문 보기